It is important to note that despite being an established cluster of differentiation of the platelet lineage, CD61 contributes to many additional functions and has been extensively implicated in cancer-promoting events, although further investigation is warranted before patients can benefit from CD61-targeted therapies [83]. Here, ITGB3 is linked to cancer.